MovDisordV3, PascalFrancis, Curation, bibRecord, 001557

Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa

Identifieur interne : 001557 ( PascalFrancis/Curation ); précédent : 001556; suivant : 001558

Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa

Auteurs : PRAMOD KUMAR PAL [Inde] ; Talakad N. Sathyaprabha [Inde] ; Prasad Tuhina [Inde] ; Kandavel Thennarasu [Inde]

Source :

Movement disorders [ 0885-3185 ] ; 2007.

RBID : Pascal:07-0181709

Descripteurs français

Pascal (Inist)
- Système nerveux pathologie, Parkinson maladie, Asymptomatique, Trouble fonctionnel, Lévodopa.

English descriptors

KwdEn :
- Asymptomatic, Dysfunction, Levodopa, Nervous system diseases, Parkinson disease.

Abstract

We performed a detailed evaluation of pulmonary function in 53 patients with idiopathic Parkinson's disease (PD) who did not have symptoms of pulmonary or cardiac dysfunction. There was a significant pulmonary dysfunction of restrictive type which partially responded to levodopa. Compared to men, women were more severely affected. Pulmonary function assessment is recommended in PD, irrespective of severity of disease.

A01	`01`	`1`		`@0 0885-3185`
A03		`1`		`@0 Mov. disord.`
A05				`@2 22`
A06				`@2 3`
A08	`01`	`1`	`ENG`	`@1 Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa`
A11	`01`	`1`		`@1 PRAMOD KUMAR PAL`
A11	`02`	`1`		`@1 SATHYAPRABHA (Talakad N.)`
A11	`03`	`1`		`@1 TUHINA (Prasad)`
A11	`04`	`1`		`@1 THENNARASU (Kandavel)`
A14	`01`			`@1 Department of Neurology, National Institute of Mental Health and Neurosciences @2 Bangalore, Karnataka @3 IND @Z 1 aut.`
A14	`02`			`@1 Department of Neurophysiology, National Institute of Mental Health and Neurosciences @2 Bangalore, Karnataka @3 IND @Z 2 aut. @Z 3 aut.`
A14	`03`			`@1 Department of Biostatistics, National Institute of Mental Health & Neurosciences @2 Bangalore, Karnataka @3 IND @Z 4 aut.`
A20				`@1 420-424`
A21				`@1 2007`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20953 @5 354000159377420260`
A44				`@0 0000 @1 © 2007 INIST-CNRS. All rights reserved.`
A45				`@0 15 ref.`
A47	`01`	`1`		`@0 07-0181709`
A60				`@1 P @3 CC`
A61				`@0 A`
A64	`01`	`1`		`@0 Movement disorders`
A66	`01`			`@0 USA`
C01	`01`		`ENG`	`@0 We performed a detailed evaluation of pulmonary function in 53 patients with idiopathic Parkinson's disease (PD) who did not have symptoms of pulmonary or cardiac dysfunction. There was a significant pulmonary dysfunction of restrictive type which partially responded to levodopa. Compared to men, women were more severely affected. Pulmonary function assessment is recommended in PD, irrespective of severity of disease.`
C02	`01`	`X`		`@0 002B17`
C02	`02`	`X`		`@0 002B17G`
C02	`03`	`X`		`@0 002B02U01`
C03	`01`	`X`	`FRE`	`@0 Système nerveux pathologie @5 01`
C03	`01`	`X`	`ENG`	`@0 Nervous system diseases @5 01`
C03	`01`	`X`	`SPA`	`@0 Sistema nervioso patología @5 01`
C03	`02`	`X`	`FRE`	`@0 Parkinson maladie @5 02`
C03	`02`	`X`	`ENG`	`@0 Parkinson disease @5 02`
C03	`02`	`X`	`SPA`	`@0 Parkinson enfermedad @5 02`
C03	`03`	`X`	`FRE`	`@0 Asymptomatique @5 09`
C03	`03`	`X`	`ENG`	`@0 Asymptomatic @5 09`
C03	`03`	`X`	`SPA`	`@0 Asintomático @5 09`
C03	`04`	`X`	`FRE`	`@0 Trouble fonctionnel @5 10`
C03	`04`	`X`	`ENG`	`@0 Dysfunction @5 10`
C03	`04`	`X`	`SPA`	`@0 Trastorno funcional @5 10`
C03	`05`	`X`	`FRE`	`@0 Lévodopa @2 NK @2 FR @5 11`
C03	`05`	`X`	`ENG`	`@0 Levodopa @2 NK @2 FR @5 11`
C03	`05`	`X`	`SPA`	`@0 Levodopa @2 NK @2 FR @5 11`
C07	`01`	`X`	`FRE`	`@0 Encéphale pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Cerebral disorder @5 37`
C07	`01`	`X`	`SPA`	`@0 Encéfalo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`ENG`	`@0 Extrapyramidal syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Extrapiramidal síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Maladie dégénérative @5 39`
C07	`03`	`X`	`ENG`	`@0 Degenerative disease @5 39`
C07	`03`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 39`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
N21				`@1 122`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001764

Links to Exploration step

Pascal:07-0181709

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa</title>
<author><name sortKey="Pramod Kumar Pal" sort="Pramod Kumar Pal" uniqKey="Pramod Kumar Pal" last="Pramod Kumar Pal">PRAMOD KUMAR PAL</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Institute of Mental Health and Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Sathyaprabha, Talakad N" sort="Sathyaprabha, Talakad N" uniqKey="Sathyaprabha T" first="Talakad N." last="Sathyaprabha">Talakad N. Sathyaprabha</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurophysiology, National Institute of Mental Health and Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Tuhina, Prasad" sort="Tuhina, Prasad" uniqKey="Tuhina P" first="Prasad" last="Tuhina">Prasad Tuhina</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurophysiology, National Institute of Mental Health and Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Thennarasu, Kandavel" sort="Thennarasu, Kandavel" uniqKey="Thennarasu K" first="Kandavel" last="Thennarasu">Kandavel Thennarasu</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Biostatistics, National Institute of Mental Health & Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">07-0181709</idno>
<date when="2007">2007</date>
<idno type="stanalyst">PASCAL 07-0181709 INIST</idno>
<idno type="RBID">Pascal:07-0181709</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001764</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001557</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa</title>
<author><name sortKey="Pramod Kumar Pal" sort="Pramod Kumar Pal" uniqKey="Pramod Kumar Pal" last="Pramod Kumar Pal">PRAMOD KUMAR PAL</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Neurology, National Institute of Mental Health and Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Sathyaprabha, Talakad N" sort="Sathyaprabha, Talakad N" uniqKey="Sathyaprabha T" first="Talakad N." last="Sathyaprabha">Talakad N. Sathyaprabha</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurophysiology, National Institute of Mental Health and Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Tuhina, Prasad" sort="Tuhina, Prasad" uniqKey="Tuhina P" first="Prasad" last="Tuhina">Prasad Tuhina</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Neurophysiology, National Institute of Mental Health and Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
<author><name sortKey="Thennarasu, Kandavel" sort="Thennarasu, Kandavel" uniqKey="Thennarasu K" first="Kandavel" last="Thennarasu">Kandavel Thennarasu</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Biostatistics, National Institute of Mental Health & Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Inde</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2007">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Asymptomatic</term>
<term>Dysfunction</term>
<term>Levodopa</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Système nerveux pathologie</term>
<term>Parkinson maladie</term>
<term>Asymptomatique</term>
<term>Trouble fonctionnel</term>
<term>Lévodopa</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We performed a detailed evaluation of pulmonary function in 53 patients with idiopathic Parkinson's disease (PD) who did not have symptoms of pulmonary or cardiac dysfunction. There was a significant pulmonary dysfunction of restrictive type which partially responded to levodopa. Compared to men, women were more severely affected. Pulmonary function assessment is recommended in PD, irrespective of severity of disease.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01>
<fA03 i2="1"><s0>Mov. disord.</s0>
</fA03>
<fA05><s2>22</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>PRAMOD KUMAR PAL</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SATHYAPRABHA (Talakad N.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>TUHINA (Prasad)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>THENNARASU (Kandavel)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Neurology, National Institute of Mental Health and Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Department of Neurophysiology, National Institute of Mental Health and Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Biostatistics, National Institute of Mental Health & Neurosciences</s1>
<s2>Bangalore, Karnataka</s2>
<s3>IND</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>420-424</s1>
</fA20>
<fA21><s1>2007</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000159377420260</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2007 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>15 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>07-0181709</s0>
</fA47>
<fA60><s1>P</s1>
<s3>CC</s3>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>We performed a detailed evaluation of pulmonary function in 53 patients with idiopathic Parkinson's disease (PD) who did not have symptoms of pulmonary or cardiac dysfunction. There was a significant pulmonary dysfunction of restrictive type which partially responded to levodopa. Compared to men, women were more severely affected. Pulmonary function assessment is recommended in PD, irrespective of severity of disease.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B17G</s0>
</fC02>
<fC02 i1="03" i2="X"><s0>002B02U01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Asymptomatique</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Asymptomatic</s0>
<s5>09</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Asintomático</s0>
<s5>09</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Trouble fonctionnel</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Dysfunction</s0>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Trastorno funcional</s0>
<s5>10</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Lévodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Levodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Levodopa</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fN21><s1>122</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001557 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001557 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:07-0181709
   |texte=   Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa

Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri